Serum lipopolysaccharide binding protein (LBP) and metabolic syndrome: a systematic review and meta-analysis.

Diabetol Metab Syndr · 2025 · PMC12269216 · PMID 40671146

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

marginally insignificantp = 0.07so close (0.05 < p ≤ 0.1)

The pooled effect size of studies using NCEP-ATP-III criteria was marginally insignificant (SMD: 5.978, 95% CI: -0.616 to 12.573, I 2 = 99.813, p = 0.07).

also in 145 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.